CDKN2A Mutations and Melanoma Risk in the Icelandic Population

BACKGROUND: Germline CDKN2A mutations have been observed in 20-40% of high-risk melanoma-prone families, however little is known about their prevalence in population-based series of melanoma cases and controls. METHODS: We resequenced the CDKN2A gene, including the p14ARF variant and promoter region...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Goldstein, Alisa M., Stacey, Simon N., Olafsson, Jon H., Jonsson, Gudbjörn F., Helgason, Agnar, Sulem, Patrick, Sigurgeirsson, Bardur, Benediktsdottir, Kristrun R., Thorisdottir, Kristin, Ragnarsson, Rafn, Kjartansson, Jens, Kostic, Jelena, Masson, Gisli, Kristjansson, Kristleifur, Gulcher, Jeffrey R., Kong, Augustine, Thorsteinsdottir, Unnur, Rafnar, Thorunn, Tucker, Margaret A., Stefansson, Kari
Formato: Artigo
Idioma:Inglês
Publicado: 2008
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC3236640/
https://ncbi.nlm.nih.gov/pubmed/18178632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jmg.2007.055376
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares